UBS cuts India GDP growth forecast to 5.1% for FY21 on fears around coronavirus outbreak, weak domestic credit growth

The GDP growth is set to slip to a decadal low of 5 percent for FY20 as per official estimates and hopes of a revival are being pinned on the next fiscal

Press Trust of India March 13, 2020 09:10:15 IST
UBS cuts India GDP growth forecast to 5.1% for FY21 on fears around coronavirus outbreak, weak domestic credit growth
  • The GDP growth is set to slip to a decadal low of 5 percent for FY20 as per official estimates and hopes of a revival are being pinned on the next fiscal

  • Apart from the coronavirus-related measures, the weak credit impulse domestically could constrain growth for the next two quarters, UBS said

  • The brokerage said it has already taken into account the benefits of the oil prices decline while making its estimate.

Mumbai: Swiss brokerage UBS sharply cut its 2020-21 GDP growth forecast for India to 5.1 percent on fears around the coronavirus outbreak and also weak credit growth domestically. The brokerage also cut its FY20 growth estimate marginally to 4.8 percent.

The GDP growth is set to slip to a decadal low of 5 percent for FY20 as per official estimates and hopes of a revival are being pinned on the next fiscal.

The brokerage's economist Tanvee Gupta Jain said even though there are only over 50 positive coronavirus cases in India so far, the fear and uncertainty over its impact could worsen near-term consumer sentiment and hit domestic demand.

UBS cuts India GDP growth forecast to 51 for FY21 on fears around <span class=coronavirus outbreak weak domestic credit growth" width="380" height="285" class="size-full wp-image-4391191" />

Representational image. Reuters.

Additionally, there will be the sectoral impact on production due to shortages of inputs in electronics, pharma and automobile sectors or reduced external demand on slowing global growth, which would also have a bearing on India's growth outlook, she explained.

Apart from the coronavirus -related measures, the weak credit impulse domestically could constrain growth for the next two quarters, it said.

"We now expect India's real GDP growth to remain weak at 5.1 percent YoY in FY21 (previously 5.6 percent) compared with 4.8 percent YoY (previously 4.9 percent) in FY20," it said, adding the growth rate will continue to be under potential in FY22, when it is expected to touch 6 percent.

The brokerage said it has already taken into account the benefits of the oil prices decline while making its estimate.

Courtesy the lower growth, India will continue to be constrained fiscally even in FY21, it said, expecting the government to breach the budgeted FY21 fiscal deficit target.

There will be a 0.30 percent slippage on the crucial number during the next fiscal over the 3.5 percent aspiration, it said.

Updated Date:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Coronavirus LIVE updates: Maharashtra remains highest contributor of new COVID-19 cases, reports 10,216 infections
India

Coronavirus LIVE updates: Maharashtra remains highest contributor of new COVID-19 cases, reports 10,216 infections

Coronavirus LIVE updates: Among the highest contributors of new COVID-19 cases are Maharashtra, Kerala, Punjab, Karnataka and Tamil Nadu. Maharashtra has reported 10,216 new cases, followed by Kerala with 2,776

BMC makes seven-day institutional quarantine mandatory for travellers arriving from Brazil
India

BMC makes seven-day institutional quarantine mandatory for travellers arriving from Brazil

Institutional quarantine for seven days and another seven days of home quarantine is already mandatory for persons arriving from the UK, Europe, South Africa and West Asia

India's slow COVID-19 vaccination rate puts gains at peril; private sector involvement must to expand coverage
India

India's slow COVID-19 vaccination rate puts gains at peril; private sector involvement must to expand coverage

It is important to reiterate that the argument of 'natural herd immunity' remains largely a thereotical one, and cannot be relied on to mitigate the disease, especially with millions of vaccine doses ready